Previous 10 | Next 10 |
AcelRx Pharmaceuticals, Inc. (ACRX) Q1 2020 Results Earnings Conference Call May 11, 2020, 04:30 PM ET Company Participants Raffi Asadorian - CFO Vince Angotti - CEO Pamela Palmer - Chief Medical Officer and Co-Founder Christian Tvetenstrand - Chairman of Surgery & Director...
AcelRx Pharmaceuticals (NASDAQ: ACRX ): Q1 GAAP EPS of -$0.20 misses by $0.04 . Revenue of $0.39M (+44.4% Y/Y) misses by $0.01M . Shares -3.5% . Press Release More news on: AcelRx Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,
REDWOOD CITY, Calif. , May 11, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its first qu...
Introduction Shares in battered biotech Tetraphase Pharmaceuticals ( TTPH ) were yesterday’s big winner in US trading, moving up 78% after La Jolla ( LJPC ) announced it had submitted a 22M non-binding all-cash proposal to acquire the company, plus an additional 12.5M in Contingen...
TetraPhase Pharmaceuticals (NASDAQ: TTPH ) discloses that it has received an unsolicited bid from La Jolla Pharmaceutical Company (NASDAQ: LJPC ) consisting of $22M in cash and an additional $12.5M payable via a contingent value right (CVR). The board is considering the offer. More news ...
REDWOOD CITY, Calif. , May 4, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release first quarter financial results after market close on Monday, May 11, 2020 . AcelRx management will host a live webcast...
LMP Automotive Holdings (NASDAQ: LMPX ) +35% . More news on: LMP Automotive Holdings, Inc., AgEagle Aerial Systems, Inc., Soligenix, Inc., Stocks on the move, , Read more ...
REDWOOD CITY, Calif. , April 30, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced that DSUVIA achieved ...
I have covered AcelRx Pharmaceuticals ( ACRX ) before, so investors should view this as an update to my previous articles . On March 16, 2020 ACRX published its fiscal year 2019 financial statements. The financials per se did not contain much new key information after the company had pre...
AcelRx Pharmaceuticals Reports Q4 Results, to Acquire Tetraphase Pharmaceuticals AcelRx ( ACRX ) reported its fourth quarter and full-year results while also announcing its plan to acquire Tetraphase Pharmaceuticals (TTPH). The company ended the year with $66.1 million in cash, cash equiva...
News, Short Squeeze, Breakout and More Instantly...
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings Talphera will begin trading on ...
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States PR Newswire Use of CRRT increased during COVID and remained at these higher utilization levels Study results demonst...
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Niyad™ Investigational Device Exemption (IDE) approval by the FDA achieved in third quarter Company plans to begin its Niyad registrational study this quarter with topl...